A case of ulcerative colitis with a variety of autoimmune diseases including ankylosing spondylitis, type 2 autoimmune pancreatitis, and primary sclerosing cholangitis.
Ankylosing spondylitis
Extraintestinal manifestations
Primary sclerosing cholangitis
Type 2 autoimmune pancreatitis
Ulcerative colitis
Journal
Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246
Informations de publication
Date de publication:
11 Jun 2024
11 Jun 2024
Historique:
received:
29
09
2023
accepted:
05
06
2024
medline:
11
6
2024
pubmed:
11
6
2024
entrez:
11
6
2024
Statut:
aheadofprint
Résumé
Ankylosing spondylitis (AS), primary sclerosing cholangitis (PSC), and autoimmune pancreatitis (AIP) are known as extraintestinal manifestations (EIMs) of ulcerative colitis (UC). A 74-year-old Japanese man visited our hospital because of white stool. He had been diagnosed with AS when he was 30 years old, and he was HLA-B27-positive. Based on various examination results, it was suspected that AIP had caused bile duct stricture. During the clinical course, he was diagnosed with UC and PSC. Then, AIP was diagnosed because he had localized pancreatic enlargement, irregular stenosis of the main pancreatic duct, PSC, and no tumor cells of pancreas. A patient with all four of these diseases, AS, AIP, PSC, and UC, is very rare. Therefore, we report a quite rare case with three EIMs (AS, PSC, and AIP) of UC.
Identifiants
pubmed: 38861196
doi: 10.1007/s12328-024-02001-1
pii: 10.1007/s12328-024-02001-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Japanese Society of Gastroenterology.
Références
Pitchumoni CS, Rubin A, Das K, et al. Pancreatitis in inflammatory bowel diseases. J Clin Gastroenterol. 2010;44:246–53.
doi: 10.1097/MCG.0b013e3181cadbe1
pubmed: 20087199
Garber A, Regueiro M. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, etiopathogenesis, and management. Curr Gastroenterol Rep. 2019. https://doi.org/10.1007/s11894-019-0698-1 .
doi: 10.1007/s11894-019-0698-1
pubmed: 31098819
Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1982–92.
doi: 10.1097/MIB.0000000000000392
pubmed: 26154136
Su CG, Judge TA, Lichtenstein GR, et al. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:307–27.
doi: 10.1016/S0889-8553(01)00019-X
pubmed: 12122740
Vavricka SR, Rogler G, Gantenbein C, et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort. Inflamm Bowel Dis. 2015;21:1794–800.
doi: 10.1097/MIB.0000000000000429
pubmed: 26020601
Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;445:552–63.
Frédérique M, Yann LB, Vinciane R, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011;106:151–6.
doi: 10.1038/ajg.2010.314
Deshpande V, Gupta R, Sainani N, et al. Subclassification of autoimmune pancreatitis. Am J Surg Pathol. 2011;35:26–35.
doi: 10.1097/PAS.0b013e3182027717
pubmed: 21164284
Song TJ, Kim JH, Kim MH, et al. Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis. J Gastroenterol Hepatol. 2012;27:700–8.
doi: 10.1111/j.1440-1746.2011.06934.x
pubmed: 21929653
Oishi Y, Yao T, Matsui T, et al. Abnormal pancreatic imaging in Crohn’s disease: prevalence and clinical features. J Gastroenterol. 2004;39:26–33.
doi: 10.1007/s00535-003-1241-5
pubmed: 14767731
Ueki T, Kawamoto K, Otsuka Y, et al. Prevalence and clinical features of autoimmune pancreatitis in Japanese patients with inflammatory bowel disease. Pancreas. 2015;44:434–40.
doi: 10.1097/MPA.0000000000000261
pubmed: 25469544
Kawa S, Okazaki K, Notohara K, et al. Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type2 autoimmune pancreatitis. J Gastroenterol. 2015;5:805–15.
doi: 10.1007/s00535-014-1012-5
Rogler G, Singh A, Kavanaugh A, et al. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161:1118–32.
doi: 10.1053/j.gastro.2021.07.042
pubmed: 34358489
Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119–27.
doi: 10.1097/00000478-200308000-00009
pubmed: 12883244
Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771–6.
doi: 10.1136/gutjnl-2012-303617
pubmed: 23232048
Fragoulis GE, Liava C, Daoussis D, et al. Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment. World J Gastroenterol. 2019;25:2162–76.
doi: 10.3748/wjg.v25.i18.2162
pubmed: 31143068
pmcid: 6526158
Olivieri I, Cantini F, Castiglione F, et al. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev. 2014;13:822–30.
doi: 10.1016/j.autrev.2014.04.003
pubmed: 24726868
Palm O, Moum B, Ongre A, et al. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease a population study the (IBSEN study). J Rheumatol. 2002;29(3):511–5.
pubmed: 11908564
Peeters H, Vander Cruyssen B, Mielants H, et al. Clinical and genetic factors associated with sacroiliitis in Crohn’s disease. J Gastroenterol Hepatol. 2008;23:132–7.
doi: 10.1111/j.1440-1746.2007.05108.x
pubmed: 17725592
Steer S, Jones H, Hibbert J, et al. Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn’s disease. J Rheumatol. 2003;30:518–22.
pubmed: 12610811
Kaplan GG, Laupland KB, Butzner D, et al. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007;102:1042–9.
doi: 10.1111/j.1572-0241.2007.01103.x
pubmed: 17313496